| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2888042 | Annals of Vascular Surgery | 2009 | 4 Pages |
Abstract
In this series, our results suggest that patients concurrently on clopidogrel can safely undergo CEA without increased risk of hematoma or neurological complications. In view of recent data demonstrating adverse outcomes in patients discontinuing clopidogrel, this study is useful in optimally managing this group of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mark D. Fleming, William M. Stone, Paul Scott, Alyssa B. Chapital, Richard J. Fowl, Samuel R. Money,